Association of 677 C>T (rs1801133) and 1298 A>C (rs1801131) polymorphisms in the MTHFR gene and breast cancer susceptibility: A meta-analysis based on 57 individual studies

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Li, Kai ^a   Li, Wusheng ^a   Dong, Xi ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALANINE; CYTOSINE; TYROSINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; DISEASE ASSOCIATION; ETHNICITY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MTHFR GENE; BREAST TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PATHOLOGY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; BREAST NEOPLASMS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84903287088     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071290     Document Type: Article

References (73)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics 2002. CA Cancer J Clin 55: 74-108.
2. Hankinson SE, Colditz GA, Willett WC (2004) Towards an integrated mod breast cancer etiology. The lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res 6: 213-218.
3. Dumitrescu RG, Cotarla I (2005) Understanding breast cancer risk-where do we stand in 2005. J Cell Mol Med 9: 208-221.
4. Lichtenstein P, Holm NV, Verkasalo PK (2000) Environmental and heritable factors in the causation of cancer. N Engl J Med 343: 78-85.
5. Bailey LB, Gregory JR (1999) Polymorphisms of methylenete-trahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr 129: 919-922. (Pubitemid 29214439)
6. Kim YI (1999) Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 10: 66-88.
7. Mason JB, Choi SW (2000) Folate and carcinogenesis: developing a unifying hypothesis. Adv Enzyme Regul 40: 127-41. (Pubitemid 30412532)
8. Choi SW, Mason JB (2002) Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 132: 2413S-2418S.
9. Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, et al (2000) Aberrant methylation of the estrogen receptor and E-cadherin 59 CpG islands increases with malignant progression in human breast cancer. Cancer Res 60: 4346-4348. (Pubitemid 32103608)
10. Soares J, Pinto AE, Cunha CV, André S, Baraõ I, et al (1999) Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression. Cancer 85: 112-118. (Pubitemid 29031364)
11. Rosenberg N, Murata M, Ikeda Y, Opare-Sem O, Zivelin A, et al(2002)The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in Whites, Japanese, and Africans. Am J Hum Genet 70: 758-762. (Pubitemid 34177929)
12. Rama Devi AR, Govindaiah V, Ramakrishna G, Naushad SM (2004) Prevalence of methylene tetrahydrofolate reductase polymorphism in South Indian population. Curr Sci 86: 440-443. (Pubitemid 39160285)
13. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113.
14. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64: 169-172. (Pubitemid 28453294)
15. Weisberg IS, Jacques PF, Selhub J, Bostom AG, Chen Z, et al (2001) The 1298A>C polymorphism in methylenetetrahy-drofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 156: 409-415. (Pubitemid 32522922)
16. Deligezer U, Akisik EE, Dalay N (2005) Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population. In Vivo 19: 889-893.
17. Ergul E, Sazci A, Utkan Z, Canturk NZ (2003) Polymorphisms in the MTHFR gene are associated with breast cancer. Tumour Biol 24: 286-290. (Pubitemid 38327990)
18. Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, et al (2005) One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res 65: 1606-1614. (Pubitemid 40270191)
19. Justenhoven C, Hamann U, Pierl CB, Rabstein S, Pesch B, et al (2005) One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiol Biomark Prev 14: 3015-3018. (Pubitemid 43068843)
20. Platek ME, Shields PG, Marian C, McCann SE, Bonner MR, et al (2009) Alcohol consumption and genetic variation in Methylenetetrahydrofolate reductase and 5-methyltetrahydrofolate homocysteine methyltransferase in relation to breast cancer risk. Cancer Epidemiol Biomark Prev 18: 2453-2459.
21. Stevens VL, McCullough ML, Pavluck AL, Talbot JT, Feigelson HS, et al (2007) Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol Biomark Prev 16: 1140-1147. (Pubitemid 46984950)
22. Chou YC, Wu MH, Yu JC, Lee MS, Yang T, et al (2006) Genetic polymorphisms of the methylenete-trahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan. Carcinogenesis 27: 2295-2300. (Pubitemid 44644819)
23. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, et al. (2003) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available: http://www.ohri.ca/programs/clinicalepidemiology/ oxford.htm. Accessed September 25, 2009.
24. Schoenleber SJ, Kurtz DM, Talwalkar JA, Roberts LR, Gores GJ (2009). Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis. Br J Cancer 100: 1385-92.
25. The Cochrane Collaborative Review Group on HIV Infection and AIDS (2009) Editorial Policy: Inclusion and Appraisal of Experimental and Non-experimental (Obser-vational) Studies. Available: http://www.igh.org/Cochrane. Accessed September 29, 2009.
26. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10: 101-29.
27. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-34. (Pubitemid 27387172)
28. Sharp L, Little J, Schofield AC, Pavlidou E, Cotton SC, et al (2002) Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett 181: 65-71. (Pubitemid 34310663)
29. Campbell IG, Baxter SW, Eccles DM, Choong DY (2002) Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res 4(6):R14.
30. Semenza JC, Delfino RJ, Ziogas A, Anton-Culver H (2003) Breast cancer risk and methylenetetrahydrofolate reductase polymorphism. Breast Cancer Res Treat 77: 217-223. (Pubitemid 36197636)
31. Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Wolf G, et al (2003) The common 677C.T gene polymorphism of methylenetetrahy- drofolate reductase gene is not associated with breast cancer risk. Breast Cancer Res Treat 81: 169-172. (Pubitemid 37211134)
32. Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, et al (2004) MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 13: 190-196. (Pubitemid 38222548)
33. Försti A, Angelini S, Festa F, Sanyal S, Zhang Z, et al (2004) Single nucleotide polymorphisms in breast cancer. Oncol Rep 11: 917-922.
34. Lee SA, Kang D, Nishio H, Lee MJ, Kim DH, et al (2004) Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women. Exp Mol Med 36: 116-121. (Pubitemid 38667919)
35. Grieu F, Powell B, Beilby J, Iacopetta B (2004) Methylenete- Trahydrofolate reductase and thymidylate synthase polymorphisms are not associated with breast cancer risk or phenotype. Anticancer Res 24: 3215-3219. (Pubitemid 39390975)
36. Lin WY, Chou YC, Wu MH, Huang HB, Jeng YL, et al (2004) The MTHFR C677T polymorphism, estrogen exposure and breast cancer risk: a nested case-control study in Taiwan. Anticancer Res 24: 3863-3868.
37. Le Marchand L, Haiman CA, Wilkens LR, Kolonel LN, Henderson BE (2004) MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 13: 2071-2077. (Pubitemid 40054300)
38. Qi J, Miao XP, Tan W, Yu CY, Liang G, et al (2004) Association between genetic polymorphisms in methylenetetrahydrofolate reductase and risk of breast cancer. Chin J Oncol 26: 287-289.
39. Kalemi TG, Lambropoulos AF, Gueorguiev M, Chrisafi S, Papazisis KT, et al (2005) The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece. Cancer Lett 222: 57-65. (Pubitemid 40544847)
40. Kalyankumar CH, Jamil K (2006) Methylene tetrahydofolate reductase (MTHFR) C677T and A1298C polymorphisms and breast cancer in South Indian population. Int J Cancer Res 2: 143-151. (Pubitemid 43676556)
41. Lissowska J, Gaudet MM, Brinton LA, Chanock SJ, Peplonska B, et al (2007) Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int J Cancer 120: 2696-2703. (Pubitemid 46651293)
42. Xu X, Gammon MD, Zhang H, Wetmur JG, Rao M, et al (2007) Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis 28: 1504-1509. (Pubitemid 47241800)
43. Hekim N, Ergen A, Yaylim I, Yilmaz H, Zeybek U, et al (2007) No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer. Cell Biochem Funct 25: 115-117. (Pubitemid 46127360)
44. Macis D, Maisonneuve P, Johansson H, Bonanni B, Botteri E, et al (2007) Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis. Breast Cancer Res Treat 106: 263-271. (Pubitemid 350045014)
45. Yu CP, Wu MH, Chou YC, Yang T, You SL, et al (2007) Breast cancer risk associated with multigenotypic poly-Morphisms in folate-metabolizing genes: a nested case-control study in Taiwan. Anticancer Res 27: 1727-1732. (Pubitemid 46807266)
46. Kan XX, Zou TN, Wu XY, Wang X (2007) Association between mTHFR genotype polymorphism and breast cancer susceptibility in human population from Yunnan. Cancer Res Prev Treat 34: 716-718.
47. Reljic A, Simundic AM, Topic E, Nikolac N, Justinic D, et al (2007) The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study. Clin Biochem 40: 981-985. (Pubitemid 47301797)
48. Inoue M, Robien K, Wang R, Van Den Berg DJ, Koh WP, et al (2008) Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study. Carcinogenesis 29: 1967-1972.
49. Kotsopoulos J, Zhang WW, Zhang S, McCready D, Trudeau M, et al (2008) Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res Treat 112: 585-593.
50. Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, et al (2008) One-carbon metab-olism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 2: 356-362. doi:10.1093/carcin/bgm295. (Pubitemid 351359675)
51. Cheng CW, Yu JC, Huang CS, Shieh JC, Fu YP, et al (2008) Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan. Breast Cancer Res Treat 111: 145-155.
52. Langsenlehner T, Renner W, Yazdani-Biuki B, Langsenlehner U (2008) Methylenetetrahydrofolatereductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis. Breast Cancer Res Treat 107: 459-460. (Pubitemid 351172116)
53. Ericson U, Sonestedt E, Ivarsson MI, Gullberg B, Carlson J, et al (2009) Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort. Cancer Epidemiol Biomarkers Prev 18: 1101-1110.
54. Gao CM, Tang JH, Cao HX, Ding JH, Wu JZ, et al (2009) MTHFR polymorphisms, dietary folate intake and breast cancer risk in Chinese women. J Hum Genet 54: 414-418.
55. Ma E, Iwasaki M, Kobayashi M, Kasuga Y, Yokoyama S, et al (2009) Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Japan. Nutr Cancer 61: 447-456.
56. Henríquez-Hernández LA, Murias-Rosales A, Hernández González A, Cabrera De León A, Díaz-Chico BN, et al (2009) Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: a case-control study. Oncol Rep 22: 1425-1433.
57. Cam R, Eroglu A, Egin Y, Akar N (2009) Dihydrofolate reduc-Tase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer. Breast Cancer Res Treat 115: 431-432.
58. Maruti SS, Ulrich CM, Jupe ER, White E (2009) MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: a nested case-control study. Breast Cancer Res 11:R91.
59. Ma E, Iwasaki M, Junko I, Hamada GS, Nishimoto IN, et al (2009) Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women. BMC Cancer 9: 122.
60. Alshatwi AA (2010) Breast cancer risk, dietary intake, and methylenetetrahydrofolate reductase (MTHFR) single nucleotide polymorphisms. Food and Chemical Toxicology 48;881-1885.
61. Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Khuhaprema T, et al (2010) Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women. Breast Cancer Res Treat 123: 885-893.
62. Weiner AS, Boyarskih UA, Voronina EN, Selezneva IA, Sinkina TV, et al (2010) Polymorphic Variants of Folate Metabolizing Genes (C677T and A1298C MTHFR and C1420T SHMT1 and G1958A MTHFD) are Not Associated with the Risk of Breast Cancer in the West Siberian Region of Russia. Molecular Biology 44: 720-727.
63. Prasad VV, Wilkhoo H (2011) Association of the Functional Polymorphism C677T in the Methylenetetrahydrofolate Reductase Gene with Colorectal, Thyroid, Breast, Ovarian, and Cervical Cancers. Onkologie 34: 422-426.
64. Hosseini M, Houshmand M, Ebrahimi A (2011) MTHFR polymorphisms and breast cancer risk. Arch Med Sci 7(1):134-7.
65. Batschauer AP, Cruz NG, Oliveira VC, Coelho FF, Santos IR, et al (2011) HFE, MTHFR, and FGFR4 genes polymorphisms and breast cancer in Brazilian women. Mol Cell Biochem 357: 247-253.
66. Mohammad NS, Yedluri R, Addepalli P, Gottumukkala SR, Digumarti RR, et al (2011) Aberrations in one-carbon metabolism induce oxidative DNA damage in sporadic breast cancer. Mol Cell Biochem 349: 159-167.
67. Naushad SM, Pavani A, Digumarti RR, Gottumukkala SR, Kutala VK (2011) Epistatic interactions between loci of one-carbon metabolism modulate susceptibility to breast cancer. Mol Biol Rep 38: 4893-4901.
68. Ziva Cerne J, Stegel V, Gersak K, Novakovic S (2011) Lack of association between methylenetetrahydrofolate reductase genetic polymorphisms and postmenopausal breast cancer risk. Molecular Medicine Reports 4: 175-179.
69. Akram M, Malik FA, Kayani MA (2012) Mutational Analysis of the MTHFR Gene in Breast Cancer Patients of Pakistani Population. Asian Pacific J Cancer Pre 13(4):1599-603.
70. Papandreou CN, Doxani C, Zdoukopoulos N, Vlachostergios PJ, Hatzidaki E, et al (2012) Evidence of Association Between Methylenetetrahydrofolate Reductase Gene and Susceptibility to Breast Cancer: A Candidate-Gene Association Study in a South-Eastern European Population. DNA Cell Biol 31(2):193-8.
71. Carvalho Barbosa Rde C, Menezes DC, Freire TF, Sales DC, Alencar VH, et al. (2012) Associations of polymorphisms of folate cycle enzymes and risk of breast cancer in a Brazilian population are age dependent. Mol Biol Rep 39: 4899-4907.
72. Lajin B, Sakur AA, Ghabreau L, Alachkar A (2012) Association of polymorphisms in one-carbon metabolizing genes with breast cancer risk in Syrian women. Tumor Biol 33: 1133-1139.
73. Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Scott RJ, et al. (2012) Association of PHB 1630 C4T and MTHFR 677 C.T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. British Journal of Cancer 106, 2016-2024.